Pharmaron
Pharmaron has a global CGT service offering both in the UK & US, with a remarkable track record in developing cell and gene therapy products for its partners. Our US Cell and Gene Therapy Lab Services team develops proprietary assays, utilizing both in vitro and in vivo models, to better predict human outcomes. To date, Pharmaron is the only CRO in the United States who has validated a potency assay for an FDA-approved gene therapy product, and we continue to support the batch release testing of this product.
Whilst our Gene Therapy CDMO has a 15-year track record in the development and manufacture of gene therapies and biologics. The team is dedicated to viral vector development and clinical manufacture from its state-of-the-art facilities located in Liverpool, UK.
Pharmaron is a premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron provides a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 19,000 employees, and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China.
